ALK and inflammatory myofibroblastic tumor: Following the first case report of IMT patients who showed durable responses to the first ALK inhibitor identified, i.e., crizotinib [113], there have been many reports of IMT patients who were successfully treated with ALK inhibitors [114,115,116].